Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:    
Net income $ 53,005 $ 31,977
Adjustments to reconcile net income to net cash provided by operating activities:    
(Income) loss from discontinued operations 492 (108)
Depreciation and amortization 17,934 11,545
Deferred income taxes 6,757 (5,315)
Non-cash equity based compensation 7,062 5,633
Change in assets and liabilities:    
Accounts receivable - billed (33,311) 7,268
Accounts receivable - unbilled (8,152) (63)
Prepaid expenses and other current assets (2,521) (4,092)
Deferred contract costs (1,413) 1,109
Accounts payable and accrued liabilities 8,728 12,298
Accrued compensation and benefits (1,877) (6,287)
Deferred revenue (2,934) 11,291
Income taxes (6,561) 8,910
Other assets and liabilities 2,285 (5,128)
Cash provided by operating activities - continuing operations 39,494 69,038
Cash used in operating activities - discontinued operations (554)  
Cash provided by operating activities 38,940 69,038
Cash flows from investing activities:    
Purchases of property and equipment (13,351) (6,576)
Capitalized software costs (8,240) (1,832)
Proceeds from settlement of final PSI price 3,380  
Proceeds from note receivable 172 272
Proceeds from sale of discontinued operations   2,240
Cash used in investing activities (18,039) (5,896)
Cash flows from financing activities:    
Repurchases of common stock (15,403) (9,749)
Employee tax withholding on restricted stock unit vesting (6,677) (3,088)
Tax benefit due to option exercises and restricted stock units vesting 4,680 2,510
Cash dividends paid (6,131) (6,061)
Stock option exercises 1,752 4,775
Repayment of long-term debt (87)  
Cash used in financing activities (21,866) (11,613)
Effect of exchange rate changes on cash and cash equivalents (1,004) 5,058
Net increase/(decrease) in cash and cash equivalents (1,969) 56,587
Cash and cash equivalents, beginning of period 189,312 172,950
Cash and cash equivalents, end of period $ 187,343 $ 229,537